Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome
@article{Parikh2003NerveGF, title={Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome}, author={V. Parikh and D. R. Evans and M. Khan and S. Mahadik}, journal={Schizophrenia Research}, year={2003}, volume={60}, pages={117-123} }
Nerve growth factor (NGF) has been found to play a crucial role in the neuroplasticity of predominantly cholinergic neurons in brain development, and neuronal survival following brain injury, which reflect in cognitive performance. Wide ranges of neurodevelopmental abnormalities have been reported in schizophrenic patients, who also show poor cognitive performance. We report plasma NGF levels in never-medicated first-episode psychotic (FEP; N=24) and chronic medicated schizophrenic patients (N… CONTINUE READING
Topics from this paper
87 Citations
Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients
- Psychology, Medicine
- Schizophrenia Research
- 2009
- 29
Brain derived neurotropic factor in first-episode psychosis
- Psychology, Medicine
- Schizophrenia Research
- 2007
- 146
Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse
- Psychology, Medicine
- Neuroscience Letters
- 2006
- 26
Reduced NGF serum levels and abnormal P300 event-related potential in first episode schizophrenia
- Psychology, Medicine
- Schizophrenia Research
- 2010
- 20
Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia
- Psychology, Medicine
- Schizophrenia Research
- 2010
- 106
Impaired nerve growth factor homeostasis in patients with bipolar disorder
- Psychology, Medicine
- The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
- 2011
- 54
Increased Plasma Brain-Derived Neurotropic Factor, Not Nerve Growth Factor-Beta, in Schizophrenia Patients with Better Response to Risperidone Treatment
- Psychology, Medicine
- Neuropsychobiology
- 2009
- 54
Peripheral blood nerve growth factor levels in major psychiatric disorders.
- Psychology, Medicine
- Journal of psychiatric research
- 2017
- 15
- Highly Influenced
Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics
- Medicine
- The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
- 2010
- 95
Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics
- Psychology, Medicine
- Neuroscience Letters
- 2009
- 28
References
SHOWING 1-10 OF 40 REFERENCES
Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses
- Psychology, Medicine
- Schizophrenia Research
- 2001
- 326
- PDF
Pharmacologic strategies for augmenting cognitive performance in schizophrenia
- Psychology, Medicine
- Biological Psychiatry
- 1999
- 144
Haloperidol administration in humans lowers plasma nerve growth factor level: evidence that sedation induces opposite effects to arousal.
- Psychology, Medicine
- Neuropsychobiology
- 1997
- 41
Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia
- Psychology, Medicine
- Schizophrenia Research
- 2002
- 72
Cognitive function in schizophrenic patients.
- Psychology, Medicine
- The Journal of clinical psychiatry
- 1996
- 155
The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
- Psychology, Medicine
- Schizophrenia bulletin
- 1999
- 980
- PDF
A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia
- Psychology, Medicine
- Schizophrenia Research
- 1999
- 131
The Cognitive Efficacy of Atypical Antipsychotics in Schizophrenia
- Medicine, Psychology
- Journal of clinical psychopharmacology
- 1998
- 105
The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.
- Psychology, Medicine
- Schizophrenia bulletin
- 1999
- 679
- PDF